# Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC

> **NCT03428295** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Dose Safety Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Glucose, Low Blood
- Glucose, High Blood

## Interventions

- **DEVICE:** Dose Safety AP system

## Key facts

- **NCT ID:** NCT03428295
- **Lead sponsor:** Dose Safety Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2017-06-22
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-08-31
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Further software development is required.
- **Last updated:** 2019-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03428295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03428295, "Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03428295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*